Vaddi Krishna
SEC insider (Form 3/4/5 filer). CIK 0001824633. CEO at Prelude Therapeutics Inc (PRLD). 13 reported Form 4/5 transactions since Sep 2024; latest on Feb 4, 2026. Located in WILMINGTON, DE.
Companies Vaddi Krishna has filed insider reports for
- Prelude Therapeutics Inc (PRLD): Director, Officer, CEO
Vaddi Krishna
CIK: 0001824633
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Prelude Therapeutics Inc
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Feb 4, 2026PRLD
Prelude Therapeutics Inc
AwardDirectEmployee Stock Option (right to buy)
837K shares- - Mar 25, 2025PRLD
Prelude Therapeutics Inc
PurchaseDirect675K shares at avg. $0.69$467K - Mar 21, 2025PRLD
Prelude Therapeutics Inc
PurchaseDirect15K shares at avg. $0.73$11K - Mar 20, 2025PRLD
Prelude Therapeutics Inc
PurchaseDirect5.4K shares at avg. $0.73$4K - Mar 17, 2025PRLD
Prelude Therapeutics Inc
PurchaseDirect9.1K shares at avg. $0.75$7K - Mar 14, 2025PRLD
Prelude Therapeutics Inc
PurchaseDirect30K shares at avg. $0.75$23K - Mar 13, 2025PRLD
Prelude Therapeutics Inc
PurchaseDirect50K shares at avg. $0.72$36K - Mar 12, 2025PRLD
Prelude Therapeutics Inc
PurchaseDirect47.5K shares at avg. $0.71$34K - Feb 4, 2025PRLD
Prelude Therapeutics Inc
AwardDirectEmployee Stock Option (right to buy)
496K shares- - Dec 31, 2024PRLD
Prelude Therapeutics Inc
PurchaseIndirect5K shares at avg. $1.21$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 4, 2026 | PRLD Prelude Therapeutics Inc | Award Employee Stock Option (right to buy) | 837,000 | - | - | Direct |
| Mar 25, 2025 | PRLD Prelude Therapeutics Inc | Purchase | 675,000 | $0.69 | $467,438 | Direct |
| Mar 21, 2025 | PRLD Prelude Therapeutics Inc | Purchase | 15,000 | $0.73 | $10,959 | Direct |
| Mar 20, 2025 | PRLD Prelude Therapeutics Inc | Purchase | 5,416 | $0.73 | $3,950 | Direct |
| Mar 17, 2025 | PRLD Prelude Therapeutics Inc | Purchase | 9,106 | $0.75 | $6,829 | Direct |
| Mar 14, 2025 | PRLD Prelude Therapeutics Inc | Purchase | 29,999 | $0.75 | $22,631 | Direct |
| Mar 13, 2025 | PRLD Prelude Therapeutics Inc | Purchase | 50,000 | $0.72 | $35,820 | Direct |
| Mar 12, 2025 | PRLD Prelude Therapeutics Inc | Purchase | 47,500 | $0.71 | $33,744 | Direct |
| Feb 4, 2025 | PRLD Prelude Therapeutics Inc | Award Employee Stock Option (right to buy) | 496,000 | - | - | Direct |
| Dec 31, 2024 | PRLD Prelude Therapeutics Inc | Purchase | 5,000 | $1.21 | $6,044 | Indirect |
1-10 of 13 transactions